These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical approach to severe Clostridium difficile infection: update for the hospital practitioner. Pant C; Sferra TJ; Deshpande A; Minocha A Eur J Intern Med; 2011 Dec; 22(6):561-8. PubMed ID: 22075280 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology, diagnosis and treatment of Clostridium difficile infection. Bassetti M; Villa G; Pecori D; Arzese A; Wilcox M Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1405-23. PubMed ID: 23253319 [TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile infection at a medical center in southern Taiwan: incidence, clinical features and prognosis. Chung CH; Wu CJ; Lee HC; Yan JJ; Chang CM; Lee NY; Chen PL; Lee CC; Hung YP; Ko WC J Microbiol Immunol Infect; 2010 Apr; 43(2):119-25. PubMed ID: 20457428 [TBL] [Abstract][Full Text] [Related]
8. Best strategies in recurrent or persistent Clostridium difficile infection. Cocanour CS Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review. Simor AE J Am Geriatr Soc; 2010 Aug; 58(8):1556-64. PubMed ID: 20646106 [TBL] [Abstract][Full Text] [Related]
10. [Clostridium-difficile-associated infections]. Eckert C; Barbut F Med Sci (Paris); 2010 Feb; 26(2):153-8. PubMed ID: 20188046 [TBL] [Abstract][Full Text] [Related]
11. [Life-threatening infections with a new strain of Clostridium difficile]. Krausz S; Bessems M; Boermeester MA; Kuijper EJ; Visser CE; Speelman P Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2081-6. PubMed ID: 16201595 [TBL] [Abstract][Full Text] [Related]
12. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection. Citron DM; Babakhani F; Goldstein EJ; Nagaro K; Sambol S; Sears P; Shue YK; Gerding DN Anaerobe; 2009 Dec; 15(6):234-6. PubMed ID: 19755166 [TBL] [Abstract][Full Text] [Related]
13. Management of Clostridium difficile infection: thinking inside and outside the box. Gerding DN; Johnson S Clin Infect Dis; 2010 Dec; 51(11):1306-13. PubMed ID: 20979491 [TBL] [Abstract][Full Text] [Related]
14. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. Johnson S J Infect; 2009 Jun; 58(6):403-10. PubMed ID: 19394704 [TBL] [Abstract][Full Text] [Related]
15. Current strategies for management of initial Clostridium difficile infection. Kelly CP J Hosp Med; 2012 Mar; 7 Suppl 3():S5-10. PubMed ID: 22407996 [TBL] [Abstract][Full Text] [Related]
16. [Clostridium difficile: a serious outpatient infection?]. Copt C; Christodoulou M; Friolet R; Berclaz R; Bettschart V; Troillet N Rev Med Suisse; 2010 Oct; 6(266):1910-3. PubMed ID: 21089556 [TBL] [Abstract][Full Text] [Related]
18. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies. Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627 [TBL] [Abstract][Full Text] [Related]
19. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027. Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327 [TBL] [Abstract][Full Text] [Related]